Dealing With Brexit: EMA Offers Firms Advice On More Thorny Questions
Executive Summary
The European Medicines Agency has updated its guidance on Brexit to offer companies more advice on the regulatory changes they will need to make in areas like transfers of MAs, rapporteurships and orphan designations, multi-country packs, and Article 58 opinions.